By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Retrophin, Inc. 

777 Third Avenue
22nd Floor
New York  New York  10017  U.S.A.
Phone: 646-564–3680 Fax:



Company News
Retrophin (RTRX) Announces Divestment Of Non-Core Assets To Turing Pharmaceuticals 10/14/2014 7:10:29 AM
Retrophin (RTRX) Announces Appointment Of Jeffrey A. Meckler To Board Of Directors 10/10/2014 7:40:58 AM
Retrophin (RTRX) Announces Appointment Of Gary Lyons To Board Of Directors 10/9/2014 10:50:33 AM
Retrophin (RTRX) Booted CEO For Multiple Stock Violations: Report 10/3/2014 11:37:16 AM
Retrophin (RTRX) Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) 10/3/2014 7:39:37 AM
Retrophin, Inc. (RTRX) Announces Leadership Reorganization 10/1/2014 8:27:57 AM
Retrophin, Inc. (RTRX) Announces Changes To Board Of Directors And Management Team 9/17/2014 11:29:46 AM
Retrophin, Inc. (RTRX), Gilead Sciences, Inc. (GILD), And Our Healthcare Values 9/15/2014 6:47:12 AM
Retrophin, Inc. (RTRX) Reports Second Quarter 2014 Financial Results 8/12/2014 8:42:17 AM
Retrophin, Inc. (RTRX) To Report Second Quarter 2014 Financial Results 8/5/2014 10:04:41 AM